US FDA carries on criticizing wayward Sun plant in Halol
The US FDA has warned Sun Pharmaceutical Industries about its facility in Halol, India just months after it withdrew approval for an epilepsy drug made at the site.
The US FDA has warned Sun Pharmaceutical Industries about its facility in Halol, India just months after it withdrew approval for an epilepsy drug made at the site.
BASF and Sumitomo have teamed up to develop an in vitro alternative to animal-based chemical testing systems.
Recipharm AB announced yesterday that it has entered into a strategic collaboration with Alcon, a Novartis company.
The end of the year is always a time for reflection, and as Andrew Schafer, ISR President told us, “2015 was a very interesting year for pharmaceutical service providers.”
GSK has temporarily halted production of Ventolin HFA inhalers at its plant in Zebulon, North Carolina while it investigates customer complaints.